Newly declassified docs shed more light on U.S. bioweapons program
By Easton Martin | March 5, 2026
Recently released documents and reports have detailed the extent of United States involvement in biological research programs located within Ukraine and other regions.
These declassified records, which have been scrutinized by Dr. Robert Malone in a report, suggest that the Department of Defense, specifically through the Defense Threat Reduction Agency, provided substantial funding and oversight for several biological laboratories.
https://www.malone.news/p/declassified-documents-link-us-bioweapons
In his report, Dr. Malone details the financial and operational ties between the United States Department of Defense and various private entities.
The documents indicate that the investment firm Rosemont Seneca Technology Partners and the firm Metabiota were instrumental in financing and coordinating various research activities. This partnership involved the study of dangerous pathogens, including anthrax and tularemia. The records reveal that the scope of these programs went beyond simple public health surveillance, involving the collection and shipment of biological samples to the United States and other Western nations.
Among the specific initiatives mentioned in the reports are Project UP 4 and Project P 781. These projects focused on the potential for migratory birds and bats to serve as vectors for the transmission of infectious diseases. According to the declassified materials, researchers tracked migration patterns to determine how pathogens could be spread across international borders. The data suggests that thousands of biological samples were processed to evaluate the risks of zoonotic spillover.
Russian military officials, led by Lieutenant General Igor Kirillov, have asserted that these documents prove the existence of an offensive biological weapons program. They claim the United States utilized these facilities to conduct high risk experiments away from domestic regulatory oversight. While American officials state that the facilities are designed for defensive purposes and the prevention of pandemics, the documents show a high level of integration between military agencies and private contractors.
The involvement of companies such as Black and Veatch is also noted within the records. These contractors were tasked with constructing the laboratory infrastructure and managing the storage of sensitive biological agents. The documentation suggests that the financial support for these facilities increased significantly over the last several years.
